Story thread · 4 reports / 3 sources
Business Watch: Japan’s Eneos to acquire TPC; FDA approves twice-rejected melanoma drug
cen.acs.org · 5h
How the coverage leans
Across 3 sources · syndicated copies counted once
Here’s what we’re watching in the chemical and pharmaceutical industries this week
First report: FDA reverses course, approves melanoma therapy after 2 rejections — beckershospitalreview.com, 1d
The coverage
The conversation · 0
Sign in to join the conversation.
No comments yet — start the thread.